Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Arrhythmogenic cardiomyopathy is a severe cardiac disorder characterized by lethal arrhythmias and sudden cardiac death, with currently no effective treatment. Plakophilin 2 (PKP2) is the most frequently affected gene. Here we show that adeno-associated virus (AAV)-mediated delivery of PKP2 in PKP2c.2013delC/WT induced pluripotent stem cell-derived cardiomyocytes restored not only cardiac PKP2 levels but also the levels of other junctional proteins, found to be decreased in response to the mutation. PKP2 restoration improved sodium conduction, indicating rescue of the arrhythmic substrate in PKP2 mutant induced pluripotent stem cell-derived cardiomyocytes. Additionally, it enhanced contractile function and normalized contraction kinetics in PKP2 mutant engineered human myocardium. Recovery of desmosomal integrity and cardiac function was corroborated in vivo, by treating heterozygous Pkp2c.1755delA knock-in mice. Long-term treatment with AAV9–PKP2 prevented cardiac dysfunction in 12-month-old Pkp2c.1755delA/WT mice, without affecting wild-type mice. These findings encourage clinical exploration of PKP2 gene therapy for patients with PKP2 haploinsufficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
Nathwani, A. C., Reiss, U. M., Tuddenham, E. G. D., Rosales, C., Chowdary, P., McIntosh, J., Della Peruta, M., Lheriteau, E., Patel, N., Raj, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407309 · Cited by 1,273
Greenberg, B., Butler, J., Felker, G. M., Ponikowski, P., Voors, A. A., Desai, A. S., Barnard, D., Bouchard, A., Jaski, B., Lyon, A. R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00082-9 · Cited by 525 · cited 1×
“After the initial drawback of the AAV1/ SERCA2α gene therapy for heart failure, which failed in a large phase IIb clinical trial 56 , gene therapy for the heart is also picking up speed again.”
MethodNathwani, A. C., Rosales, C., McIntosh, J., Rastegarlari, G., Nathwani, D., Raj, D., Nawathe, S., Waddington, S. N., Bronson, R., Jackson, S., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.274 · Cited by 345
Plakophilin-2 Is Required for Transcription of Genes That Control Calcium Cycling and Cardiac Rhythm
Cerrone, M., Montnach, J., Lin, X., Zhao, Y.-T., Zhang, M., Agullo-Pascual, E., Leo-Macias, A., Alvarado, F. J., Dolgalev, I., Karathanos, T. V., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00127-0 · Cited by 210 · cited 1×
“A study on a cardiomyocyte-specific, inducible deletion of Pkp2 in mice revealed PKP2 as a crucial regulator of calcium cycling and cardiac rhythm 15 .”
BackgroundGomes, J., Finlay, M., Ahmed, A. K., Ciaccio, E. J., Asimaki, A., Saffitz, J. E., Quarta, G., Nobles, M., Syrris, P., Chaubey, S., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr472 · Cited by 194
Caspi, O., Huber, I., Gepstein, A., Arbel, G., Maizels, L., Boulos, M., & Gepstein, L. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000188 · Cited by 186
Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy
Sommariva, E., Brambilla, S., Carbucicchio, C., Gambini, E., Meraviglia, V., Dello Russo, A., Farina, F. M., Casella, M., Catto, V., Pontone, G., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv579 · Cited by 101
Pérez-Hernández, M., van Opbergen, C. J. M., Bagwan, N., Vissing, C. R., Marrón-Liñares, G. M., Zhang, M., Torres Vega, E., Sorrentino, A., Drici, L., Sulek, K., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.060454 · Cited by 72
GJA1-20k Rescues Cx43 Localization and Arrhythmias in Arrhythmogenic Cardiomyopathy
Palatinus, J. A., Valdez, S., Taylor, L., Whisenant, C., Selzman, C. H., Drakos, S. G., Ranjan, R., Hong, T., Saffitz, J. E., & Shaw, R. M. (2023) · Circulation Research · doi:10.1161/circresaha.122.322294 · Cited by 40 · cited 1×
“While here we show therapeutic benefit in a mutant Pkp2 mouse model, another recent study utilized gene therapy to correct the arrhythmic phenotype observed in a mouse model of ACM carrying a homozygous knock-in variant in the Dsg2 gene ( Dsg2 −/− ) 34 .”
Background
Cited by
Wu, I., Zeng, A., Greer-Short, A., Aycinena, J. A., Tefera, A. E., Shenwai, R., Farshidfar, F., Van Pell, M., Xu, E., Reid, C., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00450-w · Cited by 57
“…an important caveat is that the clinical ef fi cacy of TN-401 and other PKP2 gene therapy programs or proof-of-concept studies 62 – 64 (https:// rocketpharma.com/aav-presentations-and-posters/; https://www.lexeotx.…”
Targeting arrhythmogenic macrophages: lessons learned from arrhythmogenic cardiomyopathy
Mesquita, T., & Cingolani, E. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180482 · Cited by 8
Connexin-43 Restoration Alleviates Desmosomal Arrhythmogenic Cardiomyopathy
Zhang, J., Zanella, F., Ellis, M. W., Bradford, W. H., Gutierrez-Lara, E. J., Wang, T.-M., Fujita, K., Duron, C., Karakikes, I., Lyon, R. C., et al. (2026) · Circulation: Heart Failure · doi:10.1161/circheartfailure.125.013801 · Cited by 5
Saha, D., Dutta, P., & Chakraborty, A. (2025) · Immuno · doi:10.3390/immuno5040045 · Cited by 3
Lin, X., Davidsohn, N., Boyce, S., McIntyre, M., Zhang, M., Gencarelli, M., Ascheim, D. D., Delmar, M., & Cerrone, M. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.02.030 · Cited by 1
Metadata
- Authors
- Kyriakopoulou, E., Versteeg, D., de Ruiter, H., Perini, I., Seibertz, F., Döring, Y., Zentilin, L., Tsui, H., van Kampen, S. J., Tiburcy, M., Meyer, T., Voigt, N., Tintelen, V. J. P., Zimmermann, W. H., Giacca, M., & van Rooij, E.
- Venue
- Nature Cardiovascular Research
- Published
- 2023-12-07
- Volume
- 2
- Issue
- 12
- Pages
- 1262-1276
- ISSN
- 2731-0590 (ISSN-L)
- OpenAlex
- W4389439866
- Cited by
- 71
- References
- 10
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy. https://app.cochat.ai/papers/10.1038/s44161-023-00378-9
- The paper
- Kyriakopoulou, E., Versteeg, D., de Ruiter, H., Perini, I., Seibertz, F., Döring, Y., Zentilin, L., Tsui, H., van Kampen, S. J., Tiburcy, M., Meyer, T., Voigt, N., Tintelen, V. J. P., Zimmermann, W. H., Giacca, M., & van Rooij, E. (2023). Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy. Nature Cardiovascular Research. https://doi.org/10.1038/s44161-023-00378-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.